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ABSTRACT
This study aimed to evaluate the oxidative stress status and two markers of platelet activation and
reactivity in off-pump versus on-pump coronary artery bypass surgery. Study groups of 65 patients
with double coronary artery bypass grafting were divided into cardiopulmonary bypass (CPB) and off-
pump coronary artery bypass groups. In serial blood samples, lipid hydroperoxides (LOOH), serum
paraoxonase (PON1), advanced oxidation protein products (AOPP), total sulfhydryl groups (tSHG) and
red blood cell distribution width (RDW) to platelet (Plt) ratio (RPR) and mean platelet volume (MPV)
to platelet (Plt) ratio (MPR) index were determined to compare the extent of oxidative stress and
platelet activation. The MPR and RPR rose signiﬁcantly in the post-operative period (P < 0.001) in
both groups. The increase was higher in the CPB group, but this difference reached borderline
signiﬁcance at 48 h post-operatively. The AOPP/tSHG index increased 6 h after surgery, preceded by
a signiﬁcant fall of the PON1/LOOH ratio, more evident in the CPB group. Multiple linear regression
analysis showed explicit connection between these markers and surgery-related clinical conditions.
Receiver operating characteristic analysis enabled estimation of the clinical accuracy of oxidative plus
platelet-related indices in prediction of surgery caused complications (area under the curve for the
model consisted of oxidative stress parameters and platelet activation indices was above 0.9, P <
0.001). Results showed higher oxidative stress and undesirable platelet activation in the CPB group.
Oxidative status markers and platelet activity indices showed good clinical accuracy to predict the









ACE: angiotensin-converting enzyme inhibitor;
ACT: activated clotting time;
AOPP: advanced oxidation protein products;
AUC: area under the curve;
BMI: body mass index;
CI: conﬁdence interval;
COPD: chronic obstructive pulmonary disease;
CPB: cardiopulmonary bypass;
DTNB: dinitrodithiobenzoic acid;
EuroSCORE: European system for cardiac operative risk
evaluation;
HDL: high-density lipoprotein;
ICU: intensive care unit;
LOOH: lipid hydroperoxides;
LVEF: left ventricular ejection fraction;
MDA: malondialdehyde;
MLR: multiple linear regression;
MPR: MPV to platelet ratio;
MPV: mean platelet volume;
OAD: oral antidiabetic drugs;
OPCAB: off-pump coronary artery bypass;
Plt: platelets;
PON: paraoxonase;
RDW: red blood cell distribution width;
ROC: receiver operating characteristic;
rpm: rotation or revolution per minute




SIRS: systemic inﬂammatory response syndrome;
tSHG: total sulfhydryl groups;
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Introduction
Myocardial ischemia and subsequent reperfusion during
cardiac surgery are powerful sources of reactive oxygen
species, i.e. free radicals which could cause damage in
situ, at the place of generation, as well as distant organ
damage.[1] The use of machines for cardiopulmonary
bypass (CPB) during coronary artery bypass surgery has
many advantages, which are primarily related to safe and
comfortable work for the surgeon on the arrested heart.
In addition to numerous advantages for the CPB
machine, it also has its speciﬁc drawbacks. The main dis-
advantages are related to the ﬂow and contact of the cir-
culating blood through the silicone tube systems, non-
pulsatile ﬂow, as well as the passage and trauma of
blood cells through a system of rollers.[2,3]
The oxidative stress and inﬂammatory response to
CPB are initiated by contact between heparinized blood
and non-endothelial cell surfaces. Surgery itself, as an
accidental trauma, is a trigger of oxidative stress and
acute inﬂammatory response. The continuous exposure
of heparinized blood to a non-endothelial cell surface
followed by blood reinfusion and recirculation greatly
induces the inﬂammatory response and oxidative stress
in operations employing CPB. This reaction initiates pro-
duction, release and reperfusion of vasoactive and cyto-
toxic substances.[4] It could affect many organs and
tissues. However, in most cases, the biological mecha-
nisms of autoregulation and antioxidative protection
prevent the CPB-related harmful effects and the patients’
general condition remains stable.
The idea of avoiding the potentially damaging effects
of CPB led to improvement of the techniques of myocar-
dial revascularization on the beating heart without using
CPB. This technological advancement is related to stabili-
zation of the heart during suturing of the graft anasto-
mosis to the coronary artery, as well as the application of
a protective intraluminal shunt in obtaining better pro-
tection of the heart.[5]
Myocardial revascularization without either CPB or
cardioplegia reduces the acute inﬂammatory response,
but does not prevent it.[6,7] The response to surgical
trauma, manipulation of the heart, pericardial suction,
heparin, protamine, other drugs and anaesthesia acti-
vate the extrinsic clotting system and leads to an
increase in the oxidative-stress markers, reactive oxi-
dants [8] and acute inﬂammation. The inﬂammatory
response is signiﬁcantly weaker compared to that when
CPB is used.[7,9] We have investigated the oxidative-
stress enzyme status and its relationship with cardiovas-
cular disease over the past 10 years.[1012]
Oxidative stress, inﬂammation and thrombosis are
mutually involved in the development of atherosclerosis,
especially in the later phases of disease. Chronic, sys-
temic, low-level inﬂammation and neurohumoral activa-
tion could cause an increase in the heterogeneity of
erythrocytes in circulation, and could also inﬂuence the
platelet reactivity.[13] Decreased platelet count, con-
nected with increased mean platelet volume, could be
predictive of the changes in platelet reactivity and
aggregability.[14] Red cell distribution width (RDW),
per se, is related to adverse outcomes in acute coronary
syndrome. However, the RDW to platelet count ratio
(RPR, RDW/Plt) as an even more sensitive marker of
this atherosclerosis connected risk,[15] along with the
mean platelet volume to platelet count ratio (MPR, MPV/
Plt), has not been examined with regard to CPB and off-
pump coronary artery bypass (OPCAB) surgical proce-
dures. These two indices of platelet and RBC activation
in an atherosclerotic setting could be increased as a
consequence of long-term oxidative stress and
inﬂammation.
This study was designed to investigate the effect of
OPCAB operations on the oxidative stress and the plate-
let activation that are commonly observed in patients
undergoing operation under CPB. The aim of this study
was to assess the oxidative-stress status and two new
markers of platelet activation and reactivity in two differ-
ent heart surgery modalities (CPB and OPCAB). This is
particularly relevant because larger disturbance in the
reductive balance during and after the cardiac surgery
leads to poorer outcomes and increased morbidity and
mortality in operated patients.
Subjects and methods
Study design and patients
This study was designed as a prospective cohort study at
the Department for Cardiac Surgery, Medical Military
Academy, Belgrade, Serbia. This study was done in col-
laboration with the Department for Medical Biochemis-
try, Faculty of Pharmacy, University of Belgrade.
The whole study was planned according to the ethical
standards following the Declaration of Helsinki, as
revised in 1983. The study protocol was approved by the
Hospital Ethics Committee and the Ethics Committee of
Medical Faculty, University of Belgrade, and all patients
involved in the study gave their signed informed
consent.
This study included 65 patients scheduled for an elec-
tive operation with double coronary artery bypass graft-
ing (CABG) between March 2012 and November 2015.
The patients were divided into two homogeneous
groups. In the CPB group (N D 33), the patients under-
went double CABG using CPB on a potassium-arrested
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heart, whereas in the OPCAB group (N D 32), the
patients underwent double CABG on a beating heart
without using CPB.
Exclusion criteria were: redo or emergency surgery,
concomitant valvular heart disease, ventricular aneur-
ysms, myocardial infarction within the past three months
or perioperative myocardial infarction, cerebral insult
within the past three months, usage of systems for intra-
operative blood salvage (Cell Saver machine and tubing
system), systemic inﬂammatory or malignant disease,
usage of immunosuppressive drugs, massive post-opera-
tive mediastinal bleeding, heart failure and presence of
an infection. Patients who used drugs with possible anti-
oxidant activity were also excluded from the study.
None of the patients was taking vitamins or dietary sup-
plements with established antioxidant properties before
the surgery.
EuroSCORE [16] and Body Mass Index (BMI),[17] pre-
operatively, were calculated for all patients.
Anaesthesia
The anaesthetic technique was standardized for all the
patients and consisted of balanced anaesthesia. Anaes-
thesia was induced by etomidate (0.10.2 mg/kg) and
sufentanyl (0.51 mg/kg). The patient was endotra-
cheally intubated after application of rocuronium (1 mg/
kg). Central venous cannulation (right internal jugular
vein) was carried out after induction of general anaes-
thesia. General anaesthesia was maintained with sevo-
ﬂurane (0.61.0%) and sufentanyl (0.51 mg/kg/h).
Balanced crystalloid solutions 1 mL/kg/h were used to
manage the ﬂuid balance.
Surgical procedure
In both groups, midline sternotomy and harvesting of
the left internal mammary artery as a pedicle and saphe-
nous vein grafts were followed by full exposure of the
coronary artery branches to be revascularized.
CPB group. Perfusion technique and myocardial
protection
After harvesting the bypass conduits, heparin was
administrated at a dose of 400 IU/kg to achieve a target
activated clotting time (ACT) of >450 s or more (ACT
PlusTM-Medtronic, Inc., Minneapolis, MN, USA). At the
end of CABG, heparin was neutralized by protamine-sul-
phate until the ACT was less than 160 s.
CPB operation was instituted using ascending aortic
cannulation and two-stage venous cannulation in the
right atrium. The CPB circuit was composed of a roller
pump (Stockert-S5, Sorin Group, Munich, Germany), a
low-prime hollow ﬁbre polypropylene oxygenator with
an incorporated cardiotomy reservoir (Sorin Inspire 8,
Sorin Group, Mirandola, Italy) and plasticized polyvinyl
chloride perfusion tubing systems (Tubing Set, Heart-
Lung Bypass, Sorin Group, Mirandola, Italy).
The priming solution was the same for all patients:
1000 mL of Hartmann’s solution, 150 mL of mannitol,
60 mL of 8.4% sodium bicarbonate and 5.000 UI of
heparin.
During CPB, the non-pulsatile pump ﬂow was kept at
2.22.4 L/min/m2 and perfusion pressure between 50
and 80 mmHg. CPB was managed according to the
alpha-stat principle and moderate hypothermia. The
nasopharyngeal temperature was kept at 32 C. Before
weaning from CPB, all patients were rewarmed (naso-
pharyngeal temperature 36—37 C).
Myocardial protection was achieved with 4 C cold
potassium cardioplegia (40 mmol/L of KC, 77 mmol/L of
NaC, 15 mmol/L of Mg2C, 2 mmol/L of Ca2C, 151 mmol/L
of Cl, 277 mmol/L of Glu and an appropriate Na-bicar-
bonate concentration in order to adjust the pH of the
solution at a value between 7.6 and 7.8 units). All distal
anastomoses of the bypass grafts were performed on
the arrested heart after aortic cross-clamping and the
infusion of potassium-enriched cardioplegic solution
into the coronary artery.
OPCAB group. Heart stability and myocardial
protection
After harvesting the bypass conduits, heparin was given
at a dose of 100 IU/kg to achieve ACT of 250 to 300 s. At
the end of CABG, heparin was neutralized by protamine-
sulphate until ACT was less than 160 s. Beta-blocker
drugs were used to decrease the heart rate during the
anastomosis. The patients’ temperature was maintained
normothermic (nasopharyngeal temperature of 36—
37 C) using a Hyper-Hypotermia Blanket (Maxi-Term
Adult Blanket, Cincinnati Sub-Zero, Cincinnati, OH, USA).
Mechanical stability of the coronary arteriotomy area
was achieved using an Octopus IV Tissue Stabilizer and
StarﬁshTM 2 Heart Positioner (Medtronic, Inc., Minneapo-
lis, MN, USA). For myocardial protection, soft plastic intra-
luminaly coronary ﬂow-shunt (Medtronic, Clearview,
Medtronic, Inc., Minneapolis, MN, USA) was always
passed into the coronary arteriotomy to prevent myocar-
dial ischemia during placement of distal anastomosis
and to improve visualization of the anastomosis ﬁeld. All
the anastomoses were performed on the beating heart.
Sample collection and analyses
Blood samples were collected at different time points,
according to the protocol described in Table 1. In all
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patients, the samples of venous blood were obtained by
a central venous line in the internal jugular vein. The col-
lected venous blood was drawn into test tubes
(Vaccuette Blood Collection Tubes, Greiner Bio-One
Diagnostics GmbH, Rainbach, Austria), the serum was
separated by centrifugation 3000 rpm for a period of 15
min (Multifuge 3L, Heraeus, Kendro Laboratory Products,
Osterode, Germany) and kept in 2 mL plastic tubes at
¡80 C until analysis.
Complete blood count results were obtained using a
Cell-Dyn3700 System, Abbott (Abbott Laboratories, Chi-
cago, Illinois, USA). The oxidative-stress status parame-
ters were determined using an ILAB 650 analyzer
(Instrumentation Laboratory, Milan, Italy).
Samples were obtained before skin incision (t1),
immediately after protamine-sulphate administration
(t2), 6 h (t3), 24 h (t4), 48 h (t5) and 96 h (t6) after cessation
of operation and surgical trauma. In the OPCAB group,
blood collection was the same as in the CPB group. The
blood sampling protocol for comparative measurements
of oxidative-stress markers in CPB and OPCAB patients is
presented in Table 1.
Measurement of OS parameters
Lipid hydroperoxides (LOOH) were measured according
to the method of Gay and Gebicki.[18] Advanced oxida-
tion protein products (AOPP) were determined according
to the WitkoSarsat method, using a reaction with glacial
acetic acid and potassium iodide.[19] Serum paraoxonase
(PON1) activity was measured kinetically using paraoxon
(Chem Service Inc., West Chester, PA, USA) as a substrate,
by the method of Richter and Furlong.[20] The levels of
total SH groups (tSHG) in the plasma were measured by
the Ellman method,[21] using DTNB (dinitrodithiobenzoic
acid) as a regent. The oxidative-stress indices were calcu-
lated as ratios between AOPP and tSHG (AOPP/tSHG) and
PON1 and LOOH (PON1/LOOH). The oxidative-stress sta-
tus parameters were determined using an ILAB 650 ana-
lyzer (Instrumentation Laboratory, Milan, Italy).
Statistical analysis
The parameter distribution was estimated by the
ShapiroWilk test and data were presented as mean
values with standard deviation (x̅ § SD) or median val-
ues (25th75th percentile), where appropriate.
Repeated-measures analysis of variance with the Bonfer-
roni post hoc test was performed to compare measure-
ments at different time points and independent-samples
T-test was employed for comparison between the two
surgical procedures. Multiple linear regression analysis
was used to ﬁnd a model of clinical predictors which sig-
niﬁcantly inﬂuenced the variability in the oxidative status
parameters, or platelet-related indices, as dependent
variables. The clinical accuracy of the examined parame-
ters was assessed by using receiver operating character-
istic (ROC) curve analysis towards presence of post-
operative complications. Statistical analysis was
performed with SPSS version 18.0 (IBM, Chicago, IL,
USA). In all the analyses, values were considered statisti-
cally signiﬁcant at P < 0.05.
Results and discussion
Platelet activation indices
The general clinical characteristics of the patients are
presented in Table 2.
Normal platelet stimulation is accompanied with
redox status changes, but conditions with pronounced
oxidative response, like in the atherosclerotic vessel wall,
Table 1. Blood sampling protocol for comparative measure-
ments of oxidative-stress markers in CPB and OPCAB patients.
Time All patients (CPB, OPCAB)
t1 Before skin incision
t2 After protamine administration
t3 6 h after operations
t4 24 h after operations
t5 48 h after operations
t6 96 h after operations
Table 2. Baseline clinical characteristics in the study groups.
Variable CPB group N D 32 OPCAB N D 33 P
Age (years) 63.6 § 9.8 64.7§ 9.3 ns
Gender (m/f), N (%) 25/7 21/12
(78/22) (64/36) ns
BMI (kg/m2) 29.0§ 3.7 27.3§ 3.4 0.047
Obesity 4/12/16 8/8/17 ns
Normal/overweight/obese, (12.5/37.5/50.0) (24/24/51.5)
N (%)
Hypertension, N (%) 28 (87.5) 27 (81.8) ns
Diabetes mellitus, N (%) 11 (34.4) 7 (21.2) ns
Hyperlipidemia, N (%) 25 (78) 18 (54.5) 0.045
COPD, N (%) 5 (16) 3 (9) ns
Smoking, no/yes, N (%) 10/22 11/22 ns
(31/69) (33/67)
Family history, N (%) 29 (91) 25 (76) ns
Clinical characteristics
EuroSCORE Logistic 5.50 (3.007.75) 7.0 (5.0010.00) 0.073
LVEF (%) 52.8 C 8.1 47.3 § 11.9 0.035
CPB time (min) 79.0 § 13.8 / /
ACC time (min) 44.0 § 13.7 / /
Total surgery time (min) 228.3 § 38.1 239.2 § 28.8 ns
Previous medication
b-blocker, N (%) 30 (93.8) 30 (91) ns
ACE inhibitor, N (%) 27 (84.4) 21 (63.6) ns
Calcium-antagonists, N (%) 10 (31.3) 13 (39.4) ns
Nitrates, N (%) 28 (87.5) 29 (87.9) ns
Statin, N (%) 26 (81.3) 21 (63.6) ns
OAD, N (%) 7 (21.2) 6 (18) ns
Diuretics, N (%) 8 (25) 14 (42) ns
Note: N, number of patients; ns, non-signiﬁcant; P < 0.05, 0.01, 0.001
according to independent T-test or chi-square test, where appropriate.
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could be mainly prothrombotic. It is well known that pla-
telets produce superoxide anion, and at the same time,
it could cause platelet aggregation.[13] Moreover, in the
atherosclerotic vessels there is disrupted production of
anti-aggregatory factors, such as NO and prostacyclin.
[22] CPB induces reversible platelet dysfunction, regard-
ing bleeding time prolongation through development of
hyperﬁbrinolysis and this feature returns to normal
2448 h post-operatively.[23]
On the other hand, CPB-related stress combined with
surgical stress leads the haemostatic system into a pro-
thrombotic status.[24] The ﬁne balance between antith-
rombotic and prothrombotic factors results in the actual
haemostatic status of the patients.
In this study, to assess the possible differences in two
different operative techniques which could reﬂect on
patients’ overall outcome, we compared three routine
haematological parameters, RDW, MPV and platelet
counts in two distinct study groups, and also estimated
their change during the study period. The results are pre-
sented in Figure 1.
An increase in the mean platelet volume was evident
in both study groups, but a steeper ascent was observed
in the CPB group. There was no statistical difference
between the MPV values in the two surgical groups. The
RDW signiﬁcantly rose immediately after both proce-
dures, but the increase was higher in the CPB group as
compared to OPCAB (P < 0.001 and P < 0.01, respec-
tively), and a peak value of 14.93% was observed after
24 h (Figure 1). The dynamic change in the platelet
counts followed a similar trend in both groups; still the
initial decrease in the platelet counts was steeper in the
CPB group than in the OPCAB one. The patients who
underwent a CPB procedure had signiﬁcantly lower
platelet counts compared to those subjected to OPCAB
at each time point after the surgery. The platelet counts
in both groups returned to the baseline level 96 h after
the surgical treatment.
In order to get more insight into the inﬂuence of the
surgical conditions on some selected haematological
parameters, we calculated two ratios, i.e. RPR and MPR
as quotients of RDW as well as MPV parameters and the
platelet number. The results from this part of the analysis
are presented in Table 3.
RPR and MPR increased signiﬁcantly after both surgi-
cal treatments (P < 0.001, ANOVA repeated measures),
but the increment was generally larger in CPB-treated
patients. RPR was higher in CPB patients compared to
OPCAB ones before surgery to the end of the measure-
ments (96 h), but this difference was not statistically sig-
niﬁcant; the largest difference was detected 48 h after
surgery, with borderline signiﬁcance (P D 0.051, Table 3).
This parameter reached its maximum at the 48-h time
point in both study groups, but with a larger increment
in the CPB group.
Figure 1. MPV, platelet count and RDW in the CPB and OPCAB group at six different time points: t1, before skin incision; t2, after prot-
amine sulphate administration; t3, 6 h after operations; t4, 24 h after operations; t5, 48 h after operations; t6, 96 h after operations.
Note: aP < 0.05 and aaP < 0.01 for CPB vs. OPCAB at the same time point; P < 0.05, P < 0.01, P < 0.001 vs. the t1 point.
Table 3. RDW to platelet ratio (RPR) and MPV to platelet ratio
(MPR) in the study groups.
Parameter CPB N D 32 OPCAB N D 33 P
RPR (RDW/PLT)
Before skin incision 0.068 § 0.019 0.062 § 0.017 0.248
After protamine sulphate
administration
0.096 § 0.027 0.085 § 0.054 0.269
6 h 0.086 § 0.023 0.079 § 0.044 0.417
24 h 0.092 § 0.028 0.084 § 0.043 0.330
48 h 0.102 § 0.035 0.086 § 0.031 0.051
96 h 0.075 § 0.026 0.068 § 0.024 0.234
MPR (MPV/PLT)
Before skin incision 0.039 § 0.011 0.037 § 0.011 0.435
After protamine sulphate
administration
0.053 § 0.012 0.049 § 0.035 0.564
6 h 0.048 § 0.011 0.046 § 0.030 0.640
24 h 0.053 § 0.015 0.050 § 0.028 0.558
48 h 0.062 § 0.020 0.052 § 0.020 0.056
96 h 0.043 § 0.014 0.040 § 0.0156 0.294
Note: N, number of patients; P, based on independent T-test.
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MPR also showed a distinct rise in the post-operative
period, but the difference between the two operative
techniques only reached borderline level (P D 0.056) at
the 48th h after completion of the procedures. Again, we
could see a slightly larger rise in both platelet-related
indices in the CPB group, having in mind that its starting
values (before surgery) did not differ between the two
groups of patients (Table 3).
Our results showed a distinct increase in RPR in the
CPB group and the OPCAB group from the beginning of
the investigation, until the end of observational period,
with the most signiﬁcant difference observed after 48 h,
post-operatively. This difference could be explained by a
concomitant increase in RDW and a decrease in platelet
counts, both of which were more pronounced in our
CPB patients.
It is well documented that RPR has signiﬁcant predic-
tive capability on all-cause mortality, major adverse car-
diovascular events, reinfarction, heart failure and shock
in patients with ST-segment elevation myocardial infarc-
tion.[15] Pusuroglu et al. [15] reported a cut-off value of
0.061 for this index in their study group. They stated that
the mortality incidence from cardiovascular diseases
within the following year was increased if the value of
this index was more than 0.061. In the two groups of
patients in our study, the value of this index was higher
than 0.061 from the very beginning, even before the
operation, whereas after the operation RPR values in our
study groups generally increased signiﬁcantly above the
risk value reported in Pusuroglu study,[15] reaching
0.100 value. Lippi et al. [25] reported that inﬂammation
increases RDW by erythropoetin inhibition, and this
could be related to increased production of bone mar-
row mediators. Similar results were reported by Li et al.,
[26] who showed a connection between the RDW values
and the Framingham risk score in a group of coronary
artery disease patients. Berliner et al. [27] suggested that
the RDW increase was a result of increased hemody-
namic and oxidative-stress involvement in the exacerba-
tion of coronary artery disease. The distinct rise in the
second platelet-related index, MPR, during the post-
operative time in our study, with a clear rise in the CPB
group, was due to a signiﬁcantly larger increase in MPV
compared to the baseline values and a parallel drop in
the platelet counts (Table 3). Unal et al. [28] reported
association between the MPV level and adverse events
in patients undergoing CPB. MPV is an indicator of plate-
let size and activation status: the relation is direct and
positive. Platelet enlargement may be predictive of a
thrombotic event among patients with cardiovascular
diseases. One recent study [29] used MPR for distinguish-
ing between sepsis and systemic inﬂammatory response
syndrome (SIRS). They found signiﬁcantly higher MPR
values in sepsis compared to SIRS. The values reported
in the septic patients were similar to those in our CPB
group.
During CPB, the circulating platelet pool is reduced by
dilution, adhesion, aggregation, destruction and con-
sumption. The platelet mass consists of a reduced num-
ber of morphologically normal platelets, platelets with
pseudopods formation, new and larger platelets
released from megakaryocytes,[30] partially and
completely degranulated platelets, platelet membrane
fragments and platelet microparticles. Most of the circu-
lating platelets appear structurally normal, but bleeding
times increase and remain prolonged for several hours
after protamine-sulphate administration. The functional
state of the circulating intact platelet during and early
after CPB is reduced. The platelet activation process
means that these blood cells get a larger surface, so their
shape changes from discoid to spherical, with gradual
evolution of pseudopodia. This change in platelet struc-
ture, to some extent, inﬂuences the cell volume.[31]
One of the major adverse physiological events caused
by the CPB procedure is development of ischemia at the
moment of aortic cross-clamp (ACC) and administration
of cardioplegic solution. After release of the ACC and
weaning the patient from CPB, there is development of
a reperfusion process at the moment of establishing a
normal blood ﬂow.[32] Both processes, ischemia and
reperfusion, have deleterious effects on free radicals
generation, in parallel with diminishing of the antioxi-
dant protection. Reperfusion leads to endothelial cell
dysfunction, reﬂected in vasoconstriction, platelet and
leukocyte activation, increased prooxidant generation,
and increased protein and water extravasation.[33]
Oxidative-stress assessment
As a next step in our study, we used two comprehensive
markers of oxidative stress, i.e. the ratios of two pairs of
distinct oxidative-stress parameters. We estimated the
ratio between two protein species, AOPP and total sulf-
hydryl groups content, a parameter that could give more
insight into the protein-related oxidative-stress balance
(Figure 2).
The initial values of AOPP/tSHG were similar before
the surgery. We noticed that AOPP/tSHG, as a marker of
oxidative protein damage, increased severely six hours
after the procedure. This increase was evident in both
operative techniques, but the peak was signiﬁcantly
higher in CPB-treated patients (Figure 2). This evident
rise in the oxidative protein damage was preceded by a
signiﬁcant fall in other markers of oxidative disbalance,
the PON1/LOOH ratio (lipid-related oxidative-stress
markers).
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We also measured four oxidative status markers in
order to assess the level of oxidative damage caused by
two different heart surgery modalities. Two of the
markers are protein-related (AOPP and tSHG) and the
other two have a lipid background (PON1 and LOOH).
Furthermore, AOPP and LOOH originate as a conse-
quence of free-radical damaging effects on biomole-
cules, and tSHG and PON1 are part of the antioxidant
defence system. The parameter selection was performed
according to our previous experience in oxidative-stress
analysis in vascular-system related diseases.[34] We were
especially interested in the precise course of the changes
in the markers under our study conditions, in a pro-
longed post-operative period (up to 96 h), as such data
are still scarce. According to the nature and complexity
of the parameters, we calculated their ratios, i.e. AOPP/
tSHG and PON1/LOOH as two pairs of protein or lipid
species. The index pairs were selected so that one ele-
ment from the pair reﬂects the pro-oxidative activity and
the other one, the antioxidative nature. Thus, we
obtained more convenient and easily understandable
oxidative status markers which could have a potential to
explain the actual condition of the patients resulting
from each of the heart surgery techniques, and also the
long-term atherosclerotic disease status.
The index oriented towards pro-oxidative processes,
AOPP/tSHG, did not differ signiﬁcantly before surgery
between the CPB and the OPCAB group. After an initial
fall in the early post-operative phases, we noticed a
stronger rise in the CPB group (P < 0.05 vs. OPCAB) six
hours after completion of the surgery (Figure 2). The
dynamics of the AOPP/tSHG changes were similar after
both surgical procedures, but the values were still signiﬁ-
cantly higher at all the time points in CPB vs. OPCAB until
the end of the follow-up period. Comparable results
were published by Gonenc et al.,[35] who measured the
protein carbonyl level and reported a lower degree of
oxidative stress in off-pump than in on-pump coronary
surgery. Matata et al. [36] concluded that the proteins
were unaffected by anaesthesia and the surgical proce-
dure itself, but only with CPB induction. In the same
study, the carbonyl concentration remained unchanged
during ischemia-reperfusion in the OPCAB group. It is
already well known that the CPB procedure is character-
ized with stronger activation of the haemostatic and
inﬂammatory system, primarily as a consequence of
direct interaction with circulating components of the
haemostatic system and the CPB apparatus.[32] Addi-
tionally, systemic heparinization, hemodilution and
hypothermia have a signiﬁcant inﬂuence on these two
important homeostatic systems, which are connected to
the evolution of oxidative stress. We could explain the
signiﬁcant increase in oxidative protein damage with a
fall in the enzymatic antioxidant protection capability
associated with the high-density lipoprotein (HDL)
enzyme PON1. It is important to report a clear decrease
in the antioxidant protection, which goes along with
increase in lipid peroxidation, i.e. the same process, free-
radical generation could be a cause of the both pro-
cesses, antioxidants consumption and oxidative lipid
degradation (Figure 2). Bhattacharyya et al. [37] have
proved that PON1 could signiﬁcantly inﬂuence systemic
oxidative stress in humans and have revealed a link
between PON1, atherosclerotic disease and its acute
complications. Moreover, they found direct relation
between the PON1 QQ192 genotype and increased like-
lihood of having a history of coronary artery bypass graft
surgery. Samara et al. [38] found negative correlation
between serum total homocysteine and HDL-C levels in
a group of cardiology intensive care unit (ICU) patients,
which suggests detrimental inﬂuence of oxidative stress
on HDL-C, i.e. PON1 activity under acute atherosclerotic
conditions. The study of Bicer et al. [39] found increased
malondialdehyde (MDA) in an on-pump group at 30 min
Figure 2. Oxidative-stress status indices (AOPP/tSHG and PON1/LOOH ratios) at six different time points t1, before skin incision; t2, after
protamine sulphate administration; t3, 6 h after operations; t4, 24 h after operations; t5, 48 h after operations; t6, 96 h after operations.
Note: aP < 0.05 and aaP < 0.01 for CPB vs. OPCAB at the same time point; P < 0.05, P < 0.01, P < 0.001 vs. the t1 point.
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to 24 h after the surgery. MDA is an indicator of late-
phase oxidative damage and could be compared with
LOOH measured in our study, as LOOH precedes MDA
formation. They supposed that contact of blood with
non-physiological surfaces was the primary trigger for
inﬂammation and, consequently, oxidative-stress increase
under CPB conditions. On the contrary, Stevanovic et al.
[40] showed comparable levels of oxidative stress and IL-
6, as well as the same level of selenium diminution in
CPB compared to OPCAB. They supposed that surgical
trauma was more important than CPB machine usage,
but the exact mechanism has not been elucidated yet.
Clinical characteristics and post-operative
complications
Multiple linear regression analysis (with backward elimi-
nation modality) enabled us to ﬁnd the most inﬂuential
group of surgery-related parameters which determined
the variability in platelet activity and oxidative status
indices. The initial model consisted of the following clini-
cal parameters: surgery type, total surgery time, CPB,
ACC, logistic EuroSCORE, blood transfusion, intubation
time and ICU days for all tested parameters. Table 4
presents the unstandardized coefﬁcients (B) with stan-
dard errors, 95 % conﬁdence intervals and P-values.
The best models for each of the four investigated
parameters are presented in Table 4. The surgery modal-
ity (CPB or OPCAB) was among the few main determi-
nants for RPR, AOPP/tSHG and the PON1/LOOH ratio.
The level of RPR 48 h after the end of surgery was also
determined by the surgery time (duration in minutes),
CPB time and blood transfusion (mL). The adjusted R2
value for RPR at 48 h post-operatively of 0.109 means
that 11% (calculated as 0.109 £ 100) of this parameter
variability is caused by selected model of parameters
(Table 3). According to the results of multiple linear
regression analysis the sole signiﬁcant predictor of MPR
parameter variability was EuroSCORE logistic value
(Table 4). The level of inﬂuence of this model of parame-
ters on the variation of MPR was 8% (adjusted R2 D
0.08). The oxidative marker AOPP/tSHG, at the 6-h point,
was determined by CPB, the intubation time and the ICU
days. The level of inﬂuence of the selected models for
both oxidative-stress indices was above 30%.
Thus, the results from the multiple linear regression
analysis implemented in our study revealed key clinical
determinants of haematological and oxidative status
parameters analysed here. Surgery type (CPB or OPCAB)
was among several signiﬁcant determinants of RPR,
AOPP/tSHG and PON1/LOOH values, as well as the total
surgery time (RPR), CPB (RPR, AOPP/tSHG), intubation
time (AOPP/tSHG). These explicit relations could explain
the deeper progression of oxidative processes in CPB,
which is characterized by longer surgery and intubation
time as well as the duration of ACC and CPB.
We performed ROC analysis in order to test the clini-
cal accuracy of the examined parameters towards the
presence of post-operative complications. The post-
operative complications that required a longer hospital
stay included: wound infections, superﬁcial sternal
wound infection, respiratory insufﬁciency caused by pul-
monary thromboembolism or pleural effusion and atel-
ectasis. The complication incidence in this study
population was 6 out of 65 patients (9.2%). The post-
operative complications in both groups are summarized
in Table 5.
Additionally, we constructed three models: oxidative
status Model 1 (AOPP/tSHG plus PON1/LOOH), platelet
indices Model 2 (RPR and MPR indices) and total Model 3
(oxidative status plus platelet indices), by using predic-
tive probabilities generated by logistic regression






N D 33 P
Leg wound infection, N (%) 2/32 (6.2) 0 /
Superﬁcial sternal wound infection, N (%) 1/32 (3.1) 0 /
Pleural effusion with atelectasis, N (%) 2/32 (6.2) 0 /
Pulmonary thromboembolism, N (%) 1/32 (3.1) 0 /
Total, N (%) 6/32
(18.8)
0/33 0.011
Note: N, number of patients.
P, the comparison was done using Fisher’s exact probability test.
Table 4. Multiple linear regression for platelet activity and oxida-




B (SE) 95% CI P




0.121 (0.048) 0.218 to 0.024 0.015
Total surgery time (min) 0.0004
(0.00017)
0.000090.0008 0.013
CPB (min) 0.001 (0.0006) 0.00232 to
0.000028
0.045
Blood transfusion (mL) 0.00002
(0.000012)
0.0000450.000003 0.091
MPR t5 adj. R
2 D 0.080
EuroSCORE  Logistic 0.0013 (0.0007) 0.000080.00269 0.064





263.6 (71.3) 121.1406.2 <0.001
CPB (min) 4.1 (0.89) 2.35.7 <0.001
Intubation time (h) 2.5 (0.92) 4.4 to 0.69 <0.01
ICU (days) 14.7 (7.7) 0.61830.0 0.060





1.16 (0.32) 0.509–1.803 <0.001
Note: RPR, RDW/Plt ratio; MPR, MPV/Plt ratio; adj. R2, adjusted R2, accord-
ing to multiple linear regression analysis.
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analysis. Figure 3 shows the ROC curve graph with the
most important ROC parameters: area under the curve
(AUC) and P-values for all the three models. The best
clinical accuracy in predicting the post-operative compli-
cations was achieved using Model 3, which was inte-
grated from all four measured oxidative and platelet-
related markers (AUC D 0.983, P < 0.001). Results of ROC
curves are presented in Figure 3.
The ROC-analysis-estimated clinical accuracy of the
measured haematological and oxidative-stress indices in
the development of post-operative complications
showed that none of them, as a single parameter, had
signiﬁcant discriminatory capability regarding the post-
operative complications (data not shown here). We con-
structed models consisting of all oxidative status param-
eters (Model 1), all platelet-related indices (Model 2) and
oxidative plus platelet indices (Model 3), by using predic-
tive probabilities generated by logistic regression analy-
sis. The AUC of Model 3 was above 0.9, which, according
to Hosmer and Lemeshow’s rules, presents extraordinary
discriminatory capability.[41] This result could be an
additional evidence that oxidative stress and platelet-
related factors should be measured and estimated in
heart surgery patients to predict the development of
eventual complications during post-operative recovery.
Conclusions
Oxidative stress associated with platelet activation dur-
ing CABG surgery is an important issue that is still unre-
solved. We suggest that measurement of oxidative
status and platelet activity indices should be used in pre-
diction of possible post-operative complications. We
remind that the usage of a CPB pump could be associ-
ated with some deleterious effects and post-operative
complications, including possible distant organ damage,
to a higher extent compared to OPCAB surgery. Our
results showed higher oxidative stress and unwanted
platelet activation in patients undergoing CBP surgery. It
is worth mentioning that these complications occurred
only in the CPB group. Oxidative status markers and
platelet activity indices, if measured in parallel, could be
considered to have good clinical accuracy to predict the
development of possible surgical complications.
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